|Day Low/High||17.95 / 18.50|
|52 Wk Low/High||8.74 / 21.68|
'If there are worries about the market topping out it isn't evident in [today's] price action.'
Equities are holding up well, despite concerns that good economic news increases the chances of a rate hike.
I may have to use an index play to get more money to work.
Ideally I'd like to buy a negative response to Janet Yellen tomorrow.
Company seeks to expand capabilities into additional markets
Investors eyeing a purchase of BioTelemetry Inc stock, but cautious about paying the going market price of $21.03/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2017 put at the $17 strike, which has a bid at the time of this writing of 90 cents.
There is still some good speculative action out there.
Trade-Ideas LLC identified BioTelemetry (BEAT) as a strong on high relative volume candidate
Company Announces Record Performance and Increases Guidance
There is hesitancy to chase, especially with the FOMC rate decision this afternoon.
Company provides best in class arrhythmia detection in a patch form factor
Conditions are still overbought, staying stubbornly sticky to the upside.
Keep in mind that strong action like this tends to create underlying support.
Despite the S&P 500 reaching an all-time high, there is some hesitancy to keep chasing.
The Friday action was so surprising that many were poorly positioned -- and they are still scrambling to reposition.
We have chronically underinvested bulls, nervous bears and algos.
The problem for the bears is that there are still plenty of folks trying to extract some gains from the upside.
I can't seem to put enough capital to work in individual stocks.
It's a big move today, but the recent pattern doesn't inspire hope for it to last.
We are back to the old pattern of squeezing shorts and frustrating underinvested longs.